** Shares in healthcare companies drop on Wednesday as U.S. President Donald Trump is set to unveil his reciprocal tariff plans, which he deemed "Liberation Day"
** STOXX 600 Healthcare index .SXDP falls 2.5% to its lowest since December at 0819 GMT, leading sectoral losses on wider STOXX 600 .STOXX index, which is down 0.9%
** "This might be a reaction to the tariff announcements expected today from the U.S. administration, which this time could focus on the pharmaceutical sector," an analyst says
** "(...) it's not surprising that pharma stocks have been caught up in this wave of nervousness," Susannah Streeter, senior investment and markets analyst at Hargreaves Lansdown, says
** Among single stocks, Bayer BAYGn.DE and Sanofi SASY.PA fall 4.7% and 3.3%, respectively, while Lonza LONN.S and Novo Nordisk NOVOb.CO are down around 2.7%
** Novartis NOVN.S, Roche ROG.S and Merck MRCG.DE fall between 1.6% and 2.7%
** AstraZeneca AZN.L, Bavarian Nordic BAVA.CO, GSK GSK.L and UCB UCB.BR drop 2.5%-3.7%
(Reporting by Ozan Ergenay, Isabel Demetz, Sukriti Gupta)
((ozan.ergenay@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。